ANZUPGO: The First FDA-Approved Treatment for Chronic Hand Eczema
Chronic hand eczema (CHE) is a persistent inflammatory skin condition that can make everyday activities painful and frustrating. Cracked skin, redness, itching, and recurring flare-ups often interfere with work, household tasks, and overall quality of life. ANZUPGO® (delgocitinib) is the first FDA-approved treatment developed specifically for adults with chronic hand eczema whose symptoms remain uncontrolled despite standard topical therapies.
Medical Update
- First FDA-approved treatment developed specifically for chronic hand eczema.
- Designed for adults whose symptoms remain uncontrolled with topical corticosteroids.
- Targets multiple inflammatory pathways involved in chronic hand eczema.
- May reduce redness, itching, skin cracking, and inflammation.
- Supports long-term management of persistent hand eczema.
What Is Chronic Hand Eczema?
Chronic hand eczema is a long-lasting inflammatory skin condition that primarily affects the hands. Repeated exposure to water, irritants, chemicals, and frequent hand washing can make symptoms difficult to control, particularly for people whose occupations require constant use of their hands.
Common Symptoms
- Dry, cracked skin.
- Redness and inflammation.
- Persistent itching.
- Painful skin fissures.
- Thickened or rough skin.
What Is ANZUPGO?
ANZUPGO (generic name: delgocitinib) is a prescription topical medication developed for adults with moderate to severe chronic hand eczema who have not achieved adequate symptom control with topical corticosteroids.
It represents an important advancement by targeting the underlying inflammatory pathways involved in chronic hand eczema rather than simply providing temporary symptom relief.
How ANZUPGO Works
ANZUPGO works by inhibiting multiple Janus kinase (JAK) enzymes involved in inflammatory signaling. By reducing these immune signals, the medication helps calm inflammation and support healthier skin.
How It Helps
- Reduces inflammatory cytokine activity.
- Decreases redness and swelling.
- Supports repair of the skin barrier.
- Helps interrupt the cycle of chronic inflammation.
The First FDA-Approved Treatment for Chronic Hand Eczema
ANZUPGO is the first medication specifically approved by the U.S. Food and Drug Administration for chronic hand eczema. This milestone provides a new treatment option for patients who previously had limited choices beyond topical steroids and supportive skin care.
Clinical Trial Results
Approval was supported by large Phase III clinical trials evaluating adults with moderate to severe chronic hand eczema.
Key Findings
- Improved redness and inflammation.
- Reduced skin cracking and painful fissures.
- Lower itch severity.
- Higher treatment response compared with placebo.
- Better daily hand function and comfort.
Who May Benefit From ANZUPGO?
ANZUPGO may be an appropriate treatment option for adults with moderate to severe chronic hand eczema whose symptoms continue despite using topical corticosteroids or other conventional therapies. A healthcare provider can determine whether this medication is suitable based on your medical history and the severity of your condition.
You May Be a Candidate If You Have:
- Persistent chronic hand eczema.
- Painful skin cracks or fissures.
- Recurring redness, scaling, or inflammation.
- Limited improvement with topical corticosteroids.
- Symptoms that interfere with work or daily activities.
How ANZUPGO Is Used
ANZUPGO is a prescription topical medication that should be used exactly as directed by your healthcare provider. Consistent use, together with a good skin-care routine, can help improve long-term symptom control.
- Apply as prescribed by your healthcare provider.
- Continue using moisturizers and emollients as recommended.
- Avoid stopping treatment without medical advice.
- Attend follow-up appointments to monitor progress.
Safety & Possible Side Effects
Clinical studies indicate that ANZUPGO is generally well tolerated. As with any prescription medication, side effects can occur, and patients should discuss any concerns with their healthcare provider.
Common Side Effects
- Mild application-site irritation.
- Temporary burning or stinging.
- Dryness at the application site.
- Occasional folliculitis.
How ANZUPGO May Improve Daily Life
Chronic hand eczema often affects much more than the skin. Painful hands can interfere with work, hobbies, household tasks, and even simple daily routines. By reducing inflammation and helping restore the skin barrier, ANZUPGO may improve both comfort and hand function over time.
Potential Benefits
- Healthier, less inflamed skin.
- Reduced itching and irritation.
- Fewer painful cracks and fissures.
- Greater comfort during everyday activities.
- Improved quality of life.
Clinical Perspective
Chronic hand eczema can be difficult to manage because the hands are constantly exposed to water, soaps, workplace irritants, and environmental triggers. Treatments that target the underlying inflammatory pathways, such as ANZUPGO, provide an important new option for patients whose symptoms remain difficult to control with traditional topical therapies alone.
Key Takeaway
ANZUPGO (delgocitinib) represents a major advancement in the treatment of chronic hand eczema. As the first FDA-approved therapy developed specifically for this condition, it offers eligible patients a targeted option that may reduce inflammation, improve skin healing, relieve itching, and restore comfort in daily life.
Frequently Asked Questions
Find answers to common questions about ANZUPGO and chronic hand eczema.
Is ANZUPGO the first FDA-approved treatment for chronic hand eczema?
Yes. ANZUPGO is the first medication specifically approved by the U.S. Food and Drug Administration for the treatment of chronic hand eczema in eligible adults.
How is ANZUPGO different from topical steroids?
ANZUPGO works by targeting multiple JAK pathways involved in inflammation, whereas topical corticosteroids reduce inflammation through a different mechanism. Your healthcare provider can determine which treatment is most appropriate for your condition.
How long does it take to see results?
Some patients may notice improvement within several weeks, while continued treatment may provide greater benefits over time. Individual responses vary.
Can ANZUPGO be used with moisturizers?
Yes. Moisturizers and emollients remain an important part of chronic hand eczema care and are often used alongside prescription treatments. Follow your healthcare provider’s instructions regarding application.
